Saraswati Kenkare-Mitra
Independent DirectorDr. Saraswati Kenkare-Mitra, also known as Sara, Ph.D., serves as an Independent Director of Unicycive Therapeutics, Inc. since September 06, 2023. She was President and Head of Research & Development of Alector, Inc. from December 15, 2021 to December 22, 2025, where she leads all aspects of the company’s R&D efforts in neurodegeneration, including oversight of the research, development, clinical, manufacturing, regulatory and related functions. She served as the Senior Vice President of Development Sciences of Genentech Inc. and served as its Vice President of Development Sciences. Dr. Kenkare-Mitra received her Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco, where she also stayed on as a Post-Doctoral Fellow in Clinical Pharmacology before joining Genentech. Dr. Kenkare-Mitra also holds adjunct faculty positions in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco and at the University of the Pacific in Stockton. Dr. Kenkare-Mitra is an elected member of the National Academy of Medicine (NAM) and the American Association for the Advancement of Science (AAAS). She has been widely recognized for her work in the industry with awards such as the American Association of Pharmaceutical Scientists’ Alice E. Till Advancement of Women in Pharmaceutical Sciences Recognition, Endpoints’ 20 Most Extraordinary Women in Biopharma, Fierce Pharma’s Fiercest Women in the Life Sciences and the University of California, San Francisco’s Distinguished Alumnus of the Year.
Positions
- Company NameUnicycive Therapeutics, Inc.Stock CodeUNCYPositionIndependent DirectorColleagues
- SKShalabh K. GuptaFounder, Chairman, CEO & President
- PGPramod GuptaExecutive Vice President of Pharmaceutical and Business Operations
- DJDouglas JermasekExecutive Vice President of Corporate Strategy
- JWJohn W. TownsendChief Financial Officer
- SLSandeep LaumasIndependent Director
- MSMeredith S. ManningIndependent Director
- RLRavindra L. MehtaMember of Scientific Advisory Board
